Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Treating Diabetic Patients to Very Low Lipid Targets Regresses CIMT
Link ID 11236
Title Treating Diabetic Patients to Very Low Lipid Targets Regresses CIMT
Url http://www.medscape.com/viewarticle/584795?src=rss
Description Interestingly, the regression of CIMT observed occurs in aggressively treated patients who reach treatment goals with statins alone and those treated with statins and ezetimibe combination therapy. An analysis of the FIELD trial, however, showed that fenofibrate had no effect on CIMT in diabetic patients. Heartwire
Category Articles > Cardiology
Keywords
Date Dec 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Timing of Eplerenone Initiation and Outcomes in Patients with Heart Failure after Acute Myocardial I
  Should aldosterone blockade after MI start before hospital discharge? European Journal of Heart Failure
Category:   Articles > Cardiology


2. Hypertension in Aging Patients
  Is earlier intervention needed in order to prevent negative outcomes in this growing segment of the population? Expert Review of Cardiovascular Therapy
Category:   Articles > Cardiology


3. Can Fenofibrate Prevent CVD in Type 2 Diabetes Patients?Can Fenofibrate Prevent CVD in Type 2 Diabet
  A large new study looks at fenofibrate therapy in patients with renal impairment. Medscape Diabetes & Endocrinology
Category:   Articles > Cardiology


4. FDA Safety Changes: Minipress, Letairis, Coly-Mycin M Parenteral
  The FDA has approved safety labeling revisions for prazosin HCl capsules (Minipress), ambrisentan tablets (Letairis), and colistimethate injection (Coly-Mycin M Parenteral). Medscape Medical News
Category:   Articles > Cardiology


5. Could Omega-3 Fatty Acids Help in Tackling Clopidogrel Resistance?
  A small proof-of-concept study indicates that omega-3 fatty acids might one day be useful as an additional therapy in patients undergoing PCI who are resistant to clopidogrel. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS